Kontrol Announces Funding to Accelerate the Development of Kontrol BioWater, a Real-Time Viral Testing Technology
Kontrol Technologies Corp. (“Kontrol” or the “Company”) announces that its operating subsidiary – CEM Specialties Inc. – is receiving advisory services and funding of up to $300,000 from the National Research Council of Canada Industrial Research Assistance Program (“NRC IRAP”) supporting a research and development project to accelerate its new wastewater testing technology, the Kontrol BioWater analyzer (“BioWater analyzer” or “Kontrol BioWater”), for the detection of viruses including COVID-19.
Latest Aithority Insights: Detecting, Addressing and Debunking the Hidden AI Biases
“Early viral detection is in its infancy, and we continue to build our BioCloud technology which will now include Kontrol BioWater”
“We are pleased to continue to add to our growing technology platform and intellectual property as we advance the Kontrol BioWater to the next stage of its development,” says Paul Ghezzi, CEO, Kontrol Technologies.
AI and ML News: AI: Continuing the Chase for Brain-Level Efficiency
Kontrol BioWater Innovation
The Kontrol BioWater technology will be designed with the goal of being the first real-time, in the cloud, detection technology for virus in wastewater. The current process for the collection of wastewater sampling involves on-site technicians, transporting samples to a laboratory and then undertaking a separate analysis of the wastewater. This process is time consuming and can take several days to complete. The intention of the Kontrol BioWater is to advance sampling automation for faster, on-site detection which can potentially accelerate a response plan.
“Early viral detection is in its infancy, and we continue to build our BioCloud technology which will now include Kontrol BioWater,” says Gary Saunders, President of Kontrol BioCloud.
AI ML in Marketing: AI and Big Data Analysis Used to Find Brands’ Emotional Connection
[To share your insights with us, please write to sghosh@martechseries.com]
Comments are closed.